| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673789 2-pyridinylguanidine urokinase inhibitors |
| 01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 01/06/2004 | US6673557 Methods of treatment of eye trauma and disorders |
| 01/06/2004 | US6673337 Compositions containing alpha-2-adrenergic agonist components |
| 01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 01/06/2004 | CA2247063C Treatment of macular edema |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1374891A1 Method for accelerating the rate of mucociliary clearance |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374865A1 Use of R,S-(+/-)-alpha-lipoic acid, R(+)-alpha-lipoic acid or S-(-)-alpha-lipoic acid in reduced or oxidised form, or their metabolites as well as their salts, esters or amides, for the treatment of hearing disorders |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372739A2 Stabilized therapeutic and imaging agents |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372648A2 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1228031B1 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives useful for the treatment of dry eye |
| 01/02/2004 | EP1228026B1 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 01/01/2004 | US20040002540 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002523 Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002461 Amelioration of the development of cataracts and other ophthalmic diseases |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040001868 Aerosol mixture of lipid crystals with propellant |
| 01/01/2004 | US20040001821 Topical applying kinase to eye surface |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |
| 12/31/2003 | WO2004000830A1 Novel compounds, their use and preparation |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000320A1 Water-based preparation for eye drop |
| 12/31/2003 | WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 12/31/2003 | WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2003082893A8 Theraputic methods and uses of sapogenins and their derivatives |
| 12/31/2003 | WO2003080021A3 Formulation comprising buprenorphine |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002047708A3 Selective cox-2 inhibition from edible plant extracts |
| 12/31/2003 | WO2002043578A3 Determination of risk and treatment of complications of prematurity |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2000043409A3 Alpha-conotoxin peptides |
| 12/31/2003 | CN1463729A Health care pillow containing traditional Chinese medicine |
| 12/31/2003 | CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound |
| 12/31/2003 | CN1132619C Medicine for treating myopia |
| 12/31/2003 | CN1132595C Eye disease preventing oral liquid and its preparation |
| 12/31/2003 | CN1132585C Water soluble medical chitose preparation and its preparation |
| 12/31/2003 | CN1132584C Myopia treating eye drop |
| 12/31/2003 | CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions |
| 12/31/2003 | CN1132574C Eye medicine prepn. for computer eyesight syndrome and xerophthalmia |
| 12/31/2003 | CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | CA2487346A1 Cannabinoid receptor agonists |
| 12/31/2003 | CA2485537A1 Novel compounds, their use and preparation |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670485 Vision disorders |
| 12/30/2003 | US6670396 Aspirin-triggered lipid mediators |
| 12/30/2003 | US6670389 Laulimalide derivatives |
| 12/30/2003 | US6670380 Pyridone inhibitors of fatty acid binding protein and method |
| 12/30/2003 | US6670372 Aryl ether substituted imidazoquinolines |